Beta Fund

Beta Fund is a venture capital investment firm located in Groton, Massachusetts. The firm specializes in early-stage investments, targeting emerging companies within the high-tech and biotechnology sectors. By focusing on seed and angel stage opportunities, Beta Fund aims to support innovative startups that demonstrate significant growth potential in these dynamic industries.

Dan Von Kohorn

Principal

Norman Meisner

Principal

23 past transactions

Bangyao Biological

Series B in 2022
Bangyao Biological is a cell-gene pharmaceutical company in the commercial civilization. It is a breakthrough in gene editing technology that is developing breakthrough therapies and benefiting all of humanity.

ViralGains

Series A in 2016
ViralGains, Inc. is a video marketing platform that assists advertising agencies and brands in effectively reaching their target audiences. Founded in 2012 and based in Boston, Massachusetts, the company specializes in distributing and marketing viral video content to enhance consumer engagement. Its platform integrates video into various online destinations, including blogs, social games, and social news, utilizing influencers to amplify reach. Additionally, ViralGains leverages zero-party data through interactive ads and surveys, enabling brands to discover and nurture both new and returning customers. By measuring consumer interactions with video content, the platform allows marketers to connect with audiences through relevant brand stories in preferred contexts.

Windgap Medical

Seed Round in 2014
Windgap Medical Inc. is a biotechnology company that specializes in the manufacture of compact epinephrine autoinjectors designed for the treatment of anaphylaxis, a severe allergic reaction. Established in 2011, the company is headquartered in Watertown, Massachusetts. Windgap Medical's innovative auto-injectors are filled with heat-stable epinephrine, which enhances the temperature resilience and shelf life of the medication. This feature allows healthcare providers to effectively administer epinephrine to patients experiencing acute allergy attacks, improving their chances of recovery during critical moments.

InfoBionic

Series B in 2014
InfoBionic, Inc., founded in 2011 and based in Lowell, Massachusetts, specializes in remote patient monitoring and cardiac diagnostic services through its cloud-based platform, MoMe™. The MoMe System is designed to enhance the detection of cardiac arrhythmias, allowing healthcare providers to access vital patient data anytime and anywhere. By replicating in-hospital telemetry data, the platform streams continuous electrocardiogram, respiration, and motion data to the cloud for real-time analysis. This innovation aims to improve clinical efficiency and patient care, enabling physicians to monitor and treat cardiac complications effectively.

Fetchnotes

Venture Round in 2014
Fetchnotes, Inc. is a productivity application that specializes in online note-taking services. Founded in 2012 and based in Grand Rapids, Michigan, the company offers a cloud-based platform that enables users to efficiently capture and organize short notes, such as reading lists, ideas, and shopping lists. This service streamlines the process of jotting down and managing tasks, making it easier for individuals to remain organized and productive. As of April 2015, Fetchnotes operates as a subsidiary of Driftt, Inc.

Kalion

Seed Round in 2014
Kalion, Inc. is an early-stage industrial biotechnology company based in Milton, Massachusetts, specializing in the development of glucaric acid and S-3 hydroxybutyrolactone (3-HBL) derived from renewable sources. Founded in 2010, the company employs green fermentation technology and advanced fermentation methods utilizing patented microbes to produce these valuable chemicals. Glucaric acid and 3-HBL are recognized as significant value-added chemicals from biomass, with applications in the industrial, pharmaceutical, and nutraceutical sectors. Kalion aims to transform the traditional chemical industry by offering cost-effective access to these compounds, addressing limitations related to their availability and pricing in multi-billion dollar markets.

Avaxia Biologics

Debt Financing in 2013
Avaxia Biologics, Inc. is a biopharmaceutical company based in Lexington, Massachusetts, focused on developing oral antibody therapeutics. Founded in 2005, the company aims to address gastrointestinal diseases and other serious conditions through its proprietary antibody platform. Its product pipeline includes treatments for inflammatory bowel diseases, celiac disease, necrotizing enterocolitis, radiation syndrome, oral mucositis, and metabolic disorders such as diabetes and obesity. Avaxia Biologics is also engaged in a strategic collaboration with Courtagen Life Sciences, Inc., enhancing its research and development efforts in creating gut-targeted therapeutics. As a clinical-stage organization, Avaxia Biologics is committed to improving patient outcomes by delivering innovative solutions for complex health challenges.

Covocative

Venture Round in 2013
Covocative, Inc. specializes in developing a web-based sales coaching platform designed to enhance sales performance for companies. Founded in 2011 and located in Centerville, Massachusetts, Covocative provides software solutions that empower sales managers, representatives, and trainers to set professional development goals, create actionable improvement plans, and receive targeted coaching tips. This platform is particularly beneficial for organizations with large teams of younger sales professionals who seek effective coaching and development opportunities. By leveraging cloud-based technology, Covocative's tools facilitate collaboration among distributed sales teams and foster a culture of continuous improvement. The software is customizable to align with each enterprise's existing sales processes and strategic objectives, ultimately helping sales personnel realize their full potential in a convenient and effective manner.

Respiratory Motion

Venture Round in 2013
Respiratory Motion, Inc. is a medical device company based in Waltham, Massachusetts, that specializes in the development and commercialization of respiratory monitoring devices. Founded in 2011, the company offers the ExSpiron, a point-of-care device designed to non-invasively measure critical respiratory parameters such as minute ventilation, tidal volume, and respiratory rate. With FDA clearance for its continuous monitoring systems, Respiratory Motion provides healthcare professionals with real-time data that enhances patient safety and helps in the early detection of respiratory collapse across various patient populations and clinical settings.

Fetchnotes

Seed Round in 2013
Fetchnotes, Inc. is a productivity application that specializes in online note-taking services. Founded in 2012 and based in Grand Rapids, Michigan, the company offers a cloud-based platform that enables users to efficiently capture and organize short notes, such as reading lists, ideas, and shopping lists. This service streamlines the process of jotting down and managing tasks, making it easier for individuals to remain organized and productive. As of April 2015, Fetchnotes operates as a subsidiary of Driftt, Inc.

LoopPay

Series A in 2013
LoopPay, Inc. is a mobile wallet platform that allows consumers to make payments and store various types of cards on their smartphones. The company's offerings include the LoopPay application for storing payment, loyalty, and gift cards, as well as devices such as the LoopPay Fob and ChargeCase, which enable mobile credit card transactions at retail locations. Utilizing patented Magnetic Secure Transmission (MST) technology, LoopPay allows users to make secure payments at over 10 million locations in the United States by turning existing magnetic stripe readers into contactless payment terminals, without incurring costs for merchants. The LoopPay app provides a convenient and secure way for users to manage all their cards, ensuring data protection with password and PIN security. Founded in 2006 and based in Burlington, Massachusetts, LoopPay was previously known as ACT Merchant Services and became a subsidiary of Samsung Electronics America in 2015.

ShopAdvisor

Venture Round in 2013
ShopAdvisor is a retail marketing platform that empowers brands, retailers, and shopping malls to enhance mobile and digital shopping experiences for consumers. The platform integrates real-time, contextualized information relating to shoppers, products, and locations, leveraging data analytics to offer personalized shopping experiences that extend from initial discovery to in-store visits. By continuously cataloging millions of data points, ShopAdvisor enables businesses to effectively engage consumers, encouraging them to become loyal and repeat customers. Its technology focuses on proximity marketing, allowing for tailored interactions that drive foot traffic to brick-and-mortar locations.

Crowdly

Seed Round in 2013
Crowdly is an advocate marketing platform based in Boston, Massachusetts, that enables large consumer brands to connect with and activate their authentic advocates. Founded in 2011, the company focuses on enhancing word-of-mouth promotion and brand advocacy by allowing brands to build a community of engaged supporters. Through its platform, Crowdly provides insights into advocate behavior, helping companies strengthen their branding efforts and achieve a higher return on investment. The company operates within the realms of finance, social media, advertising, and marketing, offering a comprehensive solution for brands seeking to leverage the power of advocacy in their marketing strategies.

Groupize

Series A in 2013
Groupize, Inc. is a technology company that specializes in providing solutions for hotel chains and properties to streamline the management of group requests and bookings. The company offers a customizable white label platform that enables planners to search for and book group accommodations online while accessing real-time pricing and inventory. Their services include a lead management application for processing group leads, a lead distribution portal for sharing information among hotel chains, and a group management page that assists organizers in planning their trips. Additionally, Groupize features social tools for effective communication and a content portal for property administrators to update information directly. Founded in 2012 and headquartered in Gloucester, Massachusetts, with a technology office in Boston, Groupize emphasizes data security and seamless integration with travel and expense tracking systems to enhance the experience for both planners and attendees.

Respiratory Motion

Convertible Note in 2013
Respiratory Motion, Inc. is a medical device company based in Waltham, Massachusetts, that specializes in the development and commercialization of respiratory monitoring devices. Founded in 2011, the company offers the ExSpiron, a point-of-care device designed to non-invasively measure critical respiratory parameters such as minute ventilation, tidal volume, and respiratory rate. With FDA clearance for its continuous monitoring systems, Respiratory Motion provides healthcare professionals with real-time data that enhances patient safety and helps in the early detection of respiratory collapse across various patient populations and clinical settings.

Tap 'n Tap

Venture Round in 2013
Tap 'n Tap, Inc. is an Android software solutions provider based in Cambridge, Massachusetts, established in 2008. The company specializes in helping manufacturers, operators, and retailers enhance and monetize Android devices, including smartphones and tablets. Its primary offering, Lockscreen Offers, displays full-screen mobile advertisements on the lock screens of Android devices, enabling users to engage with digital media and access special promotions from various brands. This innovative advertising solution has demonstrated significantly higher click-through rates compared to traditional mobile banners, providing premium advertisers with brand-safe inventory for impactful marketing campaigns. In addition to its advertising services, Tap 'n Tap offers a range of solutions that include custom user interface development, integration and certification, and ongoing support and maintenance, ultimately assisting device manufacturers in delivering optimized products more efficiently and increasing their profit margins.

Avaxia Biologics

Series B in 2013
Avaxia Biologics, Inc. is a biopharmaceutical company based in Lexington, Massachusetts, focused on developing oral antibody therapeutics. Founded in 2005, the company aims to address gastrointestinal diseases and other serious conditions through its proprietary antibody platform. Its product pipeline includes treatments for inflammatory bowel diseases, celiac disease, necrotizing enterocolitis, radiation syndrome, oral mucositis, and metabolic disorders such as diabetes and obesity. Avaxia Biologics is also engaged in a strategic collaboration with Courtagen Life Sciences, Inc., enhancing its research and development efforts in creating gut-targeted therapeutics. As a clinical-stage organization, Avaxia Biologics is committed to improving patient outcomes by delivering innovative solutions for complex health challenges.

Raven360

Series A in 2013
Raven360, formerly known as Content Raven, is a Framingham, Massachusetts-based company that specializes in cloud-based content security and analytics software. Founded in 2011, the company provides solutions that enable enterprises to manage and protect their intellectual property and valuable content during external sharing. Its software offers features such as content distribution control, video and audio encryption, and user behavior analytics, empowering organizations to maintain oversight and security of their sensitive information.

InfoBionic

Series A in 2013
InfoBionic, Inc., founded in 2011 and based in Lowell, Massachusetts, specializes in remote patient monitoring and cardiac diagnostic services through its cloud-based platform, MoMe™. The MoMe System is designed to enhance the detection of cardiac arrhythmias, allowing healthcare providers to access vital patient data anytime and anywhere. By replicating in-hospital telemetry data, the platform streams continuous electrocardiogram, respiration, and motion data to the cloud for real-time analysis. This innovation aims to improve clinical efficiency and patient care, enabling physicians to monitor and treat cardiac complications effectively.

Respiratory Motion

Convertible Note in 2013
Respiratory Motion, Inc. is a medical device company based in Waltham, Massachusetts, that specializes in the development and commercialization of respiratory monitoring devices. Founded in 2011, the company offers the ExSpiron, a point-of-care device designed to non-invasively measure critical respiratory parameters such as minute ventilation, tidal volume, and respiratory rate. With FDA clearance for its continuous monitoring systems, Respiratory Motion provides healthcare professionals with real-time data that enhances patient safety and helps in the early detection of respiratory collapse across various patient populations and clinical settings.

Covocative

Venture Round in 2013
Covocative, Inc. specializes in developing a web-based sales coaching platform designed to enhance sales performance for companies. Founded in 2011 and located in Centerville, Massachusetts, Covocative provides software solutions that empower sales managers, representatives, and trainers to set professional development goals, create actionable improvement plans, and receive targeted coaching tips. This platform is particularly beneficial for organizations with large teams of younger sales professionals who seek effective coaching and development opportunities. By leveraging cloud-based technology, Covocative's tools facilitate collaboration among distributed sales teams and foster a culture of continuous improvement. The software is customizable to align with each enterprise's existing sales processes and strategic objectives, ultimately helping sales personnel realize their full potential in a convenient and effective manner.

Avaxia Biologics

Series B in 2012
Avaxia Biologics, Inc. is a biopharmaceutical company based in Lexington, Massachusetts, focused on developing oral antibody therapeutics. Founded in 2005, the company aims to address gastrointestinal diseases and other serious conditions through its proprietary antibody platform. Its product pipeline includes treatments for inflammatory bowel diseases, celiac disease, necrotizing enterocolitis, radiation syndrome, oral mucositis, and metabolic disorders such as diabetes and obesity. Avaxia Biologics is also engaged in a strategic collaboration with Courtagen Life Sciences, Inc., enhancing its research and development efforts in creating gut-targeted therapeutics. As a clinical-stage organization, Avaxia Biologics is committed to improving patient outcomes by delivering innovative solutions for complex health challenges.

Respiratory Motion

Convertible Note in 2012
Respiratory Motion, Inc. is a medical device company based in Waltham, Massachusetts, that specializes in the development and commercialization of respiratory monitoring devices. Founded in 2011, the company offers the ExSpiron, a point-of-care device designed to non-invasively measure critical respiratory parameters such as minute ventilation, tidal volume, and respiratory rate. With FDA clearance for its continuous monitoring systems, Respiratory Motion provides healthcare professionals with real-time data that enhances patient safety and helps in the early detection of respiratory collapse across various patient populations and clinical settings.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.